The U.S. will approve the third dose of the COVID-19 vaccine for people with weakened immunity

The regulator will decide in the next two days, CNN notes.

The U.S. Food and Drug Administration (FDA) is expected to approve the use of a booster dose of Pfizer and Moderna coronavirus vaccines for people with weakened immunity in the next two days. This was reported by CNN, citing an informed source.

“The Food and Drug Administration is closely monitoring the data obtained from the studies,” an FDA representative told CNN. “The Department, together with the Centers for Disease Control and Prevention, is evaluating possible options [for the use of the third dose] and will share information soon.”

According to the TV channel, the date of the announcement may be postponed, but previously we are talking about the next 48 hours.

Earlier, the director of the National Institute of Allergic and Infectious Diseases of the United States, Anthony Fauci, said that the use of a booster dose of the vaccine against the new coronavirus might be required for people with weakened immunity.